TY - JOUR A2 - Huang, Yuli AU - Xu, Ji-Hong AU - Liang, Jia-Ping AU - Zhu, Chu-Jun AU - Lian, Yu-Jun PY - 2022 DA - 2022/11/04 TI - Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies SP - 5451947 VL - 2022 AB - Pulmonary hypertension (PH) is a type of clinical pathophysiological syndrome characterized by a progressive increase in pulmonary vascular resistance and subsequent progressive failure of the right heart function, and is a common complication of many diseases.流水干细胞自主归宿受疾病破坏的地点,修复受损组织并参与系统炎和免疫响应调控,这些反应具有良好的临床应用前景外细胞微粒学等生物活动通过规范细胞间通信参与各种生物活动散入外细胞环境的异类也会影响宿主免疫系统sc-EVs作为MSC处理过程的中间人,携带生物活性物质,如蛋白质、脂质、mRNA和mic-RNAMSC-EVs治疗法比细胞处理法安全,已证明有效调控大型词类支持反炎倍型类,这些词类与肺高血压前科模型中的语理和功能效益密切相关。活性物质的主要作用及其潜在的医学价值吸引了研究人员的广泛关注。文章审查MSC-EV处理肺高血压最近研究的作用和相关机制,为今后临床应用提供基础SN-0896-4327UR-https://doi.org/101155/2022/5451947DO-10.1155/2022/5451947JF-干预心学PB-HindawiKW-ER